The six-gate roadmap, Strategy Lock through Phase 2 Enablement, shows that the sequencing discipline built for one IND is what determines whether a company’s development engine can repeat for a second and third program.
White Paper
From IND to Phase 2: The 24 Months That Determine Whether Your Development Platform Scales
Related Resources
All Resources
post
Understanding the Phases of FDA Approval for Drug Development
Read More
post
The Next Generation of Regulatory Submissions: Exploring the Benefits of eCTD 4.0
Read More
post
Understanding the Nuances of a Clinical Study Protocol
Read More
post
Why Regulatory Affairs is Important in Drug Approval
Read More
Let's move from science to success.
Let’s Talk